 |
|
Pneumocystis carinii Pneumonia During Immunosuppressive Therapy for Antineutrophil Cytoplasmic Autoantibody—Positive Vasculitis
Uyen Huynh-Do, MD;
Hubert Gantenbein, MD;
Ulrich Binswanger, MD
Arch Intern Med. 1995;155(8):872-874.
Abstract
We describe two human immunodeficiency virus—negative patients who developed Pneumocystis carinii pneumonia (PCP) during immunosuppressive therapy for antineutrophil cytoplasmic autoantibody—positive vasculitis and review the literature regarding the pathogenesis and frequency of PCP. The recent application of DNA amplification techniques suggests that PCP developing in immunocompromised individuals does not necessarily result from reactivation of a dormant focus, but may arise as de novo infection after exposure to an exogenous source of P carinii. In addition, several reports about clusters of PCP cases raise concern about the risk of a nosocomial transmission of P carinii. Therefore, PCP should be added to the list of bronchopulmonary complications in patients with antineutrophil cytoplasmic autoantibody—positive vasculitis who are receiving long-term steroid therapy.
(Arch Intern Med. 1995;155:872-874)
Author Affiliations
From the Division of Nephrology, Department of Internal Medicine, University Hospital, Zurich, Switzerland.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A Survey of Rheumatologists' Practice for Prescribing Pneumocystis Prophylaxis
CETTOMAI et al.
The Journal of Rheumatology 2010;37:792-799.
ABSTRACT
| FULL TEXT
Rare diseases bullet 10: Small vessel vasculitis of the lung
Schwarz and Brown
Thorax 2000;55:502-510.
FULL TEXT
Pneumocystis carinii Pneumonia Without Acquired Immunodeficiency Syndrome: More Patients, Same Risk
Sepkowitz et al.
Arch Intern Med 1995;155:1125-1128.
ABSTRACT
|
